Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study
ConclusionsContrast echocardiography was a valid, complementary tool for echocardiographic analysis of dogs with MMVD. Pimobendan decreased nPTT in dogs affected by MMVD. Myocardial perfusion was not different in dogs with severe MMVD.
Source: Australian Veterinary Journal - Category: Veterinary Research Authors: SM Apple, G Menciotti, L Braz ‐Ruivo, S Crosara, J Häggström, M Borgarelli Tags: SMALL ANIMALS Source Type: research
More News: Cardiology | Enalapril | Eyes | Furosemide | Heart | Men | Perfusion | Study | Veterinary Research